Literature DB >> 19508303

Quercetin inhibits fatty acid and triacylglycerol synthesis in rat-liver cells.

G V Gnoni1, G Paglialonga, L Siculella.   

Abstract

BACKGROUND: Quercetin plays a cardiovascular protective role because of its antioxidant capacity and ability to modulate dyslipidemia. As alterations in hepatic lipid synthesis are crucial to the regulation of serum lipid levels, we investigated the quercetin effect on lipogenesis in rat liver cells.
MATERIALS AND METHODS: The effect of quercetin on the rate of synthesis of fatty acids, cholesterol, neutral lipids, phospholipids and very-low-density lipoproteins (VLDL) was investigated in rat hepatocyte suspensions following [1-(14)C]acetate incorporation into these lipid fractions. Enzyme activities of acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS) as well as diacylglycerol acyltransferase (DGAT) and 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoA-R), pace-setting steps of de novo fatty acid, triacylglycerol (TAG) and cholesterol synthesis respectively were assayed in digitonin-permeabilized hepatocytes.
RESULTS: Within 30 min of quercetin addition to the hepatocytes, inhibition (IC50 approximately 25 microM) of fatty acid synthesis occurred. A reduction in label incorporation mainly into TAG was observed. Among neosynthesized fatty acids, palmitic acid formation was greatly reduced, suggesting that enzymatic step(s) of de novo fatty synthesis was affected. Only ACC activity was noticeably reduced, but no change in FAS activity was observed. DGAT activity was also inhibited. The decreased intracellular TAG content was paralleled by a reduction in acetate incorporation into VLDL-TAG. Conversely, cholesterol synthesis and HMG-CoA-R were not significantly affected by quercetin.
CONCLUSIONS: In hepatocytes from normal rats, the quercetin-induced decrease in both de novo fatty acid and TAG synthesis, with a consequent reduction in VLDL-TAG formation, may represent a potential mechanism contributing to the reported hypotriacylglycerolemic effect of quercetin.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19508303     DOI: 10.1111/j.1365-2362.2009.02167.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  27 in total

Review 1.  Quercetin: Its Main Pharmacological Activity and Potential Application in Clinical Medicine.

Authors:  Dengyu Yang; Tiancheng Wang; Miao Long; Peng Li
Journal:  Oxid Med Cell Longev       Date:  2020-12-30       Impact factor: 6.543

2.  Acute intake of quercetin from onion skin extract does not influence postprandial blood pressure and endothelial function in overweight-to-obese adults with hypertension: a randomized, double-blind, placebo-controlled, crossover trial.

Authors:  Verena Brüll; Constanze Burak; Birgit Stoffel-Wagner; Siegfried Wolffram; Georg Nickenig; Cornelius Müller; Peter Langguth; Birgit Alteheld; Rolf Fimmers; Peter Stehle; Sarah Egert
Journal:  Eur J Nutr       Date:  2016-02-29       Impact factor: 5.614

3.  Insulin- and leptin-regulated fatty acid uptake plays a key causal role in hepatic steatosis in mice with intact leptin signaling but not in ob/ob or db/db mice.

Authors:  Fengxia Ge; Shengli Zhou; Chunguang Hu; Harrison Lobdell; Paul D Berk
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-01       Impact factor: 4.052

4.  SSO and other putative inhibitors of FA transport across membranes by CD36 disrupt intracellular metabolism, but do not affect FA translocation.

Authors:  Anthony G Jay; Jeffrey R Simard; Nasi Huang; James A Hamilton
Journal:  J Lipid Res       Date:  2020-02-26       Impact factor: 5.922

5.  Rapid down-regulation of hepatic lipid metabolism by phenolic fraction from extra virgin olive oil.

Authors:  Paola Priore; Donatella Caruso; Luisa Siculella; Gabriele V Gnoni
Journal:  Eur J Nutr       Date:  2014-10-09       Impact factor: 5.614

6.  Quercetin suppresses MIP-1α-induced adipose inflammation by downregulating its receptors CCR1/CCR5 and inhibiting inflammatory signaling.

Authors:  Hye-Ji Noh; Chu-Sook Kim; Ji-Hye Kang; Jun-Young Park; Suck-Young Choe; Soon-Myoung Hong; Hoon Yoo; Taesun Park; Rina Yu
Journal:  J Med Food       Date:  2013-12-10       Impact factor: 2.786

Review 7.  Flavonoids as dietary regulators of nuclear receptor activity.

Authors:  Yishai Avior; David Bomze; Ory Ramon; Yaakov Nahmias
Journal:  Food Funct       Date:  2013-04-19       Impact factor: 5.396

8.  Modulation of PI3K-LXRα-dependent lipogenesis mediated by oxidative/nitrosative stress contributes to inhibition of HCV replication by quercetin.

Authors:  Sandra Pisonero-Vaquero; María V García-Mediavilla; Francisco Jorquera; Pedro L Majano; Marta Benet; Ramiro Jover; Javier González-Gallego; Sonia Sánchez-Campos
Journal:  Lab Invest       Date:  2014-02-03       Impact factor: 5.662

9.  Herbal products: benefits, limits, and applications in chronic liver disease.

Authors:  Anna Del Prete; Antonella Scalera; Maddalena Diana Iadevaia; Agnese Miranda; Claudio Zulli; Laura Gaeta; Concetta Tuccillo; Alessandro Federico; Carmelina Loguercio
Journal:  Evid Based Complement Alternat Med       Date:  2012-09-06       Impact factor: 2.629

10.  Quercetin ameliorates hyperglycemia and dyslipidemia and improves antioxidant status in type 2 diabetic db/db mice.

Authors:  Soo-Mi Jeong; Min-Jung Kang; Ha-Neul Choi; Ji-Hye Kim; Jung-In Kim
Journal:  Nutr Res Pract       Date:  2012-06-30       Impact factor: 1.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.